# Cemex S.A.B. de C.V. Sponsored ADR (CX) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Basic Materials / Construction Materials. Price $11.03, market value $15.9 billion.

## Valuation
- **P/E (trailing): 31.5×** (5-yr avg 545.9×, 3-yr avg 709.7×). Cemex S.A.B. de C.V. Sponsored ADR trades at 31.5× trailing earnings, well below its own five-year average of 545.9×: cheap by its own standards. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 12.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.00**. A PEG of 0.00 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.9×**. Each dollar of revenue is priced at 0.9×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.3×**. The shares trade at 1.3× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 7.3×**. Enterprise value is 7.3× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 10.2%** (5-yr avg 1.2%). Free cash flow equals 10.2% of the market value, above its five-year average of 1.2%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 3.2%**. The inverse of the P/E: 3.2% of the price is earned each year.

## Profitability
- **Gross margin: 33.6%**. Cemex S.A.B. de C.V. Sponsored ADR keeps 33.6% of revenue after the direct cost of what it sells.
- **Operating margin: 12.5%**. 12.5% of revenue is left after running the business.
- **Net margin: 6.0%**. 6.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 7.2%**. 7.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 6.2%**. Return on all capital, debt included, is 6.2%.
- **Return on assets: 1.7%**. Each dollar of assets produces 1.7% of profit.

## Growth
- **Revenue growth (1 yr): -0.4%** (3-yr 3.1%/yr, 5-yr 5.0%/yr). Revenue fell 0.4% over the last year, against 5.0% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 2970.4%** (3-yr 223.6%/yr). Earnings per share rose 2970.4%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 7.6%/yr**. Free cash flow has compounded at 7.6% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.51**. Debt is 0.51 times equity, moderate leverage.
- **Net debt / EBITDA: 1.7×**. It would take 1.7 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 4.2×**. Operating profit covers interest 4.2× over, a safe margin.
- **Current ratio: 0.83** (quick 0.62). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.98**. A Z-score of 1.98 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.89%** ($0.10 per share, trailing). Cemex S.A.B. de C.V. Sponsored ADR yields 0.89%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 13%** (9% of free cash flow). 13% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 2**. 2 straight years of increases.

## Price and momentum
- **Total return (1 yr): 20.0%** (YTD -3.6%, 3-mo -11.3%). The shares are up 20.0% over twelve months including dividends.
- **From 52-week high: -19.3%** (26.3% above the low). Trading 19% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 1.40** (volatility 37%). Beta of 1.40 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CX · Page: https://foliofundamentals.com/stocks/cx

Not investment advice.